Pharmacological Evidence for Extracts and Secondary Metabolites from Plants of the Genus Hibiscus

    April 2009 in “ Food Chemistry
    Elemar Gomes Maganha, Rafael da Costa Halmenschlager, Renato Moreira Rosa, João Antônio Pêgas Henriques, Ana Lı́gia Lia de Paula Ramos, Jenifer Saffi
    Image of study
    TLDR Hibiscus plant extracts may have health benefits like lowering blood pressure and protecting the heart.
    The document from 2010 reviews the pharmacological properties of extracts and secondary metabolites from plants of the genus Hibiscus, particularly focusing on the species Hibiscus sabdariffa, Hibiscus tiliaceus, and Hibiscus rosa-sinensis. It highlights their potential bioactive properties, including antioxidant, cardioprotective, antihypertensive, antiproliferative, anti-inflammatory, hepatoprotective, and antidiabetic activities. The review notes the traditional medicinal uses of these species and the scientific investigations into their biological activities. For Hibiscus sabdariffa, a clinical trial involving 54 patients demonstrated a significant reduction in blood pressure after daily consumption of an aqueous extract, and another trial with 39 patients showed its effectiveness in blood pressure reduction comparable to the drug captopril. The document emphasizes the need for further research to isolate and identify the bioactive components responsible for these effects and suggests the genus Hibiscus, especially H. sabdariffa, as a potential source for developing new drugs for various conditions, including cardiovascular diseases and cancer.
    Discuss this study in the Community →

    Research cited in this study

    1 / 1 results

    Related Community Posts Join

    4 / 4 results

      community Are there ever going to be any oral DHT blocking treatments in the future?

      in Product  6 upvotes 1 year ago
      The discussion revolves around the need for future oral DHT blockers for hair loss treatment that don't have the side effects of current options like Finasteride and Dutasteride. One user suggests that the future of hair loss treatment will likely be topical anti-androgens, as they can target hair follicles without affecting the entire system.

      community So we’re just ok with taking a research chemical now?

      in Treatment  181 upvotes 3 years ago
      The conversation discusses the use of RU58841, a non-FDA approved research chemical for hair loss, with mixed opinions on its safety and effectiveness. Some users are willing to try it as a last resort after other treatments like Minoxidil and Finasteride failed, while others express concerns about potential long-term side effects and lack of official research.

    Similar Research

    5 / 274 results